Revolution Medicines (RVMD) FCF Margin (2019 - 2023)
Revolution Medicines' FCF Margin came in at -16560.65% for Q4 2023, down 16138.83 percentage points from -421.81% a year earlier.
Powered by 
Analysis
Revolution Medicines (RVMD) FCF Margin (2019 - 2023) Analysis & Trends
For FY2023, Revolution Medicines' FCF Margin was -3094.14%, down 2429.31 percentage points from FY2022.
- FCF Margin has declined in each of the last five years, with a five-year change of -3092.72 percentage points (FY2018 to FY2023).
- Going back by year, FCF Margin was -664.83% in FY2022 (-141.84 pp), -522.99% in FY2021 (-283.37 pp), -239.62% in FY2020 (-135.30 pp) and -104.32% in FY2019 (-102.91 pp).
- The Q4 2023 figure represents the lowest quarterly FCF Margin in data going back to Q1 2019.
- Year-over-year, FCF Margin increased in two of the last seven quarters, with an average year-over-year change of -2329.22 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q3 2022 (a gain of 1717.73 percentage points), and the weakest in Q4 2023 (a drop of 16138.83 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.01% |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -16,560.65% |
| Jun 30, 2023 | -1,784.52% |
| Mar 31, 2023 | -914.59% |
| Dec 31, 2022 | -421.81% |
| Sep 30, 2022 | -1,646.66% |
| Jun 30, 2022 | -638.90% |
| Mar 31, 2022 | -752.82% |
| Dec 31, 2021 | -427.57% |
| Sep 30, 2021 | -3,364.40% |
| Jun 30, 2021 | -406.91% |
| Mar 31, 2021 | -402.97% |
| Dec 31, 2020 | -299.43% |
| Sep 30, 2020 | -218.85% |
| Jun 30, 2020 | -204.14% |
| Mar 31, 2020 | -247.89% |
| Dec 31, 2019 | -100.61% |
| Sep 30, 2019 | -119.65% |
| Jun 30, 2019 | -98.79% |
| Mar 31, 2019 | -98.33% |
API Access
Revolution Medicines FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();